A recent study by Future Market Insights (FMI) forecasts robust growth for the global alcohol use disorder treatment market, projecting a 6.4% compound annual growth rate (CAGR) from 2023 to 2033. By the end of this period, the market garnered a market value of USD 700 million in 2023, and is expected to reach a valuation of USD 1300 million, reflecting the growing demand for effective treatment solutions driven by rising awareness and technological advancements.
The expansion of the AUD treatment industry is largely attributed to increasing drug awareness campaigns, preventative programs, and the development of innovative treatments. In recent years, global initiatives aimed at reducing alcohol abuse have led to a significant rise in patient awareness, greater government involvement, and a focus on addiction reduction. These campaigns, which utilize various media channels including television, newspapers, and information booklets, have played a pivotal role in educating the public about the risks of alcohol abuse and the availability of treatment options.
Technological advancements in treatment options have further contributed to the market’s growth. New medications that not only regulate alcohol cravings but also prevent deterioration of the patient’s condition are helping more individuals successfully overcome alcohol use disorder. This has led to an increase in the number of individuals seeking treatment and, ultimately, a higher success rate in managing AUD.
In North America, the market is currently the largest, driven by the availability of advanced treatment medications and a well-established healthcare infrastructure. The region also faces a significant public health challenge, with more than 30,000 deaths annually in the U.S. from liver cirrhosis, the majority of which are alcohol-related. However, Asia-Pacific is expected to see the fastest growth in the coming years. With the largest and fastest-growing population, particularly in India and China, the region’s growing vulnerable adult population and rising demand for AUD treatment make it a key area for market expansion.
The global push for better education, more accessible treatment options, and government support for addiction recovery programs are expected to continue driving the AUD treatment market’s expansion. As new treatments become more widely available and public awareness continues to rise, the global outlook for alcohol use disorder treatment remains positive.
Key Takeaways from the Market Study:
- FMI projects the global alcohol use disorder treatment market to expand at a 6.4% value CAGR by 2033
- The global alcohol use disorder treatment market is estimated at a market value of USD 700 million
- The global alcohol use disorder treatment market is expected to garner a market value of USD 1,300 million
- Europe is forecasted to be the most lucrative for alcohol use disorder treatment market growth
- North America is expected to grow at a CAGR of 6.2% during the forecast period 2023-2033.
- As per Future Market Insights, the Asia Pacific is expected to grow at a CAGR of 6% during the forecast period 2023-2033.
- The alcohol abuse segment is expected to hold the largest market share for alcohol use disorder treatment in the forecast period 2023-2033.
“Drug awareness programmes and addiction & recovery facilities among the people are considerably contributing to market growth. One of the most important aspects of the development of the alcohol use disorder treatment industry is the use of awareness campaigns and associated anticipatory programmes,” says an analyst at FMI.
Interest in Market Trends: Get Detailed Analysis and Insights with Our Comprehensive Report!
Market Competition:
Prominent players in the alcohol use disorder treatment market are Alkermes, Teva Pharmaceutical Industries Ltd., BioCorRx, Inc., Adial Pharmaceuticals, ADDEX THERAPEUTICS, Kinnov Therapeutics, Opiant Pharmaceuticals, Omeros Corporation, GlaxoSmithKline plc and Merck & Co. Inc.
- In December 2022, BioCorRx Inc., a developer and provider of innovative treatment programmes for substance abuse and related disorders announced that it has partnered with Government Plus LLC, a leading provider of private sector healthcare to veterans, to expand its Beat Addiction Recovery Program across the country.
- In November 2022, Opiant Pharmaceuticals Inc. announced that it has entered into a final merger agreement with Indivior Inc, a subsidiary of Indivior PLC, to be acquired. According to the terms of the deal, Indivior will buy all of Opiant’s existing shares for $20.00 per share in cash at closure, plus contingent value rights (CVRs) reflecting possible further payments of up to $8.00 per share over a seven-year period if accomplished.
Key Segments Profiled in the Alcohol Use Disorder Treatment Industry Survey:
By Disorder Type:
- Alcohol Abuse
- Alcohol Dependence
- Alcohol Addiction
- Alcoholism
By Treatment Type:
- Medication
- Therapy
- Multidisciplinary Treatment
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
